High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
There is increasing interest in prevention of pertussis in adults by vaccination, but little is
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …

[HTML][HTML] Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 …

S Mangarule, S Palkar, M Mitra, MD Ravi, R Singh… - Vaccine: X, 2022 - Elsevier
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …

[PDF][PDF] Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type b combination vaccine …

KB Phua, SH Quak, FS Lim, P Goh… - Annals Academy of …, 2008 - researchgate.net
Introduction: In recent years, acellular pertussis combination vaccines have facilitated
compliance with and coverage of the national immunisation programme in Singapore. This …

Immunogenicity and reactogenicity associated with an 18‐month booster dose of a new diphtheria‐tetanus‐whole cell pertussis vaccine

T Nolan, G Hogg, MA DARCY, JB Carlin… - … of paediatrics and …, 1998 - Wiley Online Library
Objective: To establish safety and immunogenicity of a reformulated whole cell pertussis
based diphtheria‐tetanus‐pertussis vaccine (DTPw) at the 18‐month booster stage …

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and …

SA Halperin, B Smith, M Russell… - The Pediatric …, 2000 - journals.lww.com
Background. Pertussis is increasingly recognized as an important cause of cough illness in
adolescents and adults. Purpose. To evaluate the safety and antibody response to a single …

The present and future control of pertussis

JD Cherry - Clinical Infectious Diseases, 2010 - academic.oup.com
Currently, there are 2 tetanus and reduced antigen content diphtheria and acellular
pertussis vaccines (Tdap vaccines; called dTpa in Europe) available for the immunization of …

[HTML][HTML] Safety and reactogenicity of a low-dose diphtheria-tetanus-acellular pertussis vaccine (BoostrixTM) in pre-school Indian children

A Bose, AP Dubey, D Gandhi, A Pandit… - Indian …, 2007 - indianpediatrics.net
Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …

[HTML][HTML] Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to …

T John, M Voysey, LM Yu, N McCarthy, M Baudin… - Vaccine, 2015 - Elsevier
This serological follow up study assessed the kinetics of antibody response in children who
previously participated in a single centre, open-label, randomised controlled trial of low …

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™) A Review of its Use as a Single-Dose Booster Immunization

JE Frampton, GM Keating - BioDrugs, 2006 - Springer
Reduced-antigen, combined diphtheria, tetanus, and acellular pertactin-containing pertussis
vaccine (dTpa; Boostrix™) contains reduced quantities of the same toxoids/antigens found …

Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus …

J Embree, B Law, T Voloshen… - Clinical and Vaccine …, 2015 - Am Soc Microbiol
An understanding of the antibody persistence elicited by a combined tetanus, diphtheria, 5-
component acellular pertussis, and inactivated poliovirus vaccine (Tdap-IPV) after …